14 results
PRE 14A
GLUE
Monte Rosa Therapeutics Inc
12 Apr 23
Preliminary proxy
4:07pm
Not Disclose Gender
Part I: Gender Identity
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian … drug discovery and medicinal chemistry across Europe, the U.S. and Asia. Dr. Mayweg is currently a member of the board of directors of Black Diamond
DEF 14A
GLUE
Monte Rosa Therapeutics Inc
27 Apr 22
Definitive proxy
4:10pm
of Directors
Female
Male
Non-Binary
Did Not Disclose Gender
Part I: Gender Identity
Directors
Part II: Demographic Background
African American or Black … . Mayweg is currently a member of the board of directors of Black Diamond Therapeutics, Inc., a biopharmaceutical company. Dr. Mayweg received a D
10-K
ri7vcung5dn
29 Mar 22
Annual report
4:15pm
10-Q
sqpw7cm12bk hkij5
12 Aug 21
Quarterly report
4:22pm
424B4
ikzwycblpd rdw0ovl
25 Jun 21
Prospectus supplement with pricing info
6:08am
S-1/A
buvait 2fu
9 Jun 21
IPO registration (amended)
4:51pm
S-1
mfi1sov ligsrfjpj
4 Jun 21
IPO registration
9:07am
DRS/A
pvol6
21 May 21
Draft registration statement (amended)
12:00am
DRS
sfgpg4qi8znv
19 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next